George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.925
Bid: 18.40
Ask: 19.45
Change: -0.275 (-1.43%)
Spread: 1.05 (5.707%)
Open: 19.20
High: 0.00
Low: 0.00
Prev. Close: 19.20
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Annual General Meeting

24 Nov 2022 16:00

RNS Number : 5133H
BATM Advanced Communications Ld
24 November 2022
 

LEI: 213800FLQUB9J289RU66

24 November 2022

 

BATM Advanced Communications Limited

("BATM" or "the Company") 

 

Notice of Annual General Meeting

 

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, gives notice that the Annual General Meeting ("AGM" or the "Meeting") of the Company is to be held at 12.00pm Israel time (10.00am UK time) on 21 December 2022 at the Company's registered office at 4 Ha'harash Street, Nave Ne'eman Industrial Area, P.O.B. 7318, 4524075 Hod Hasharon, Israel. In order to enable shareholder engagement and participation for those unable to physically attend the Meeting, shareholders will be able to access the Meeting via videoconference.

 

Among the items to be considered at the Meeting, which remain conditional on shareholder approval, are the following:

 

· The grant of the following long-term incentives to Mr. Moti Nagar as Executive Director and CEO of the Company effective 1 January 2023:

the grant of options to purchase ordinary shares of NIS 0.01 each in the Company ("Ordinary Shares"), with grant date of 1 January 2023 (the "Grant Date") (subject to compliance with any applicable law, rule and/or regulation), that will vest equally in phases over three years from the Grant Date, at a total grant value of 2% of the value of the Company on the Grant Date. The exercise price will be the average closing price of the shares on the London Stock Exchange in the 30 days prior to the Grant Date.

 

· A one-time grant to Dr. Gideon Chitayat, Chairman of BATM, of share-based compensation at a total grant value of $210,000, with a grant date of 1 January 2023, subject to compliance with any applicable law, rule and/or regulation.

 

· An amendment to the Company's articles of association so that the Company will be authorised to indemnify, commit to indemnify and exempt all current and future directors and office holders in the Company, in accordance with the Israeli Companies Law and the common practice in Israeli publicly traded companies, provided that the maximum aggregate liability per case or per year to all office holders cumulatively does not exceed an amount equal to 24.99% of the average of the Company's profits (as calculated for classification purposes) for the last three financial years (losses should be taken as nil profit and included in this average), is limited to the difference between the amount of the financial liability and the sum of amounts received for that liability by virtue of insurance policies or other indemnity agreements, and the exemption is limited to 4.99% of any class tests as set out in the FCA Listing Rules (in aggregate with all other transactions or arrangements with the same related party (and any of its associates) in any 12 month period) ("the Indemnification"). As all current and future directors of the Company are party to the Indemnification, the Indemnification constitutes a transaction with a related party with the Indemnification classified as a smaller related party transaction pursuant to Listing Rule 11.1.10.

 

IMPORTANT INFORMATION ABOUT THE AGM

 

Shareholders will not be able to vote at the Meeting via the videoconference. Shareholders attending the Meeting via videoconference are therefore strongly encouraged to submit their vote in advance of the AGM, in accordance with the Notes to the Notice of Annual General Meeting.

 

Further information on the resolutions, notes and details on how to attend the AGM via videoconference can be found in the Notice of AGM that, along with forms of proxy and direction, has today been made available on BATM's website at: www.batm.com.  

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525 

Moti Nagar, Chief Financial Officer

 

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

+44 20 7408 4050 

 

Gracechurch Group

Harry Chathli, Claire Norbury

+44 20 4582 3500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOABIBMTMTATBFT
Date   Source Headline
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review
14th Apr 20229:30 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.